Valneva SE Logo

Valneva SE

Specialty vaccine company developing and commercializing vaccines for infectious diseases.

VLA | PA

Overview

Corporate Details

ISIN(s):
AT0000A10B99 (+3 more)
LEI:
969500DIVIP5VKNW4948
Country:
France
Address:
6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN

Description

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-03-13 17:45
2018_03_13_Chikungunya Phase 1 Initiation_FR
French 341.7 KB
2018-03-05 18:00
Valneva - Declaration février 2018
French 114.0 KB
2018-02-26 22:15
2018_02_26_Phase 1 Initiation VLA1601_EN
English 191.0 KB
2018-02-26 22:15
2018_02_26_Phase 1 Initiation VLA1601_FR
French 182.3 KB
2018-02-06 18:00
Valneva - Declaration janvier 2018
French 113.9 KB
2018-01-05 18:00
Valneva - Declaration décembre 2017
French 114.4 KB
2018-01-05 18:00
Valneva - Bilan semestriel contrat de liquidité
French 79.4 KB
2017-12-06 18:00
Valneva - Declaration novembre 2017
French 114.4 KB
2017-12-04 19:00
2017_12_04_VLA_JP Morgan_PR_EN
English 329.7 KB
2017-12-04 19:00
2017_12_04_VLA_JP Morgan_PR_FR
French 331.5 KB
2017-11-30 17:50
2017_11_30_VLA_US Private_PR_FR
French 458.3 KB
2017-11-30 17:50
2017_11_30_VLA_US Private_PR_EN
English 403.6 KB
2017-11-07 23:00
2017_11_07_VLA_US Military_PR_EN
English 271.2 KB
2017-11-07 23:00
2017_11_07_VLA_US Military_PR_FR
French 329.4 KB
2017-11-06 18:00
Valneva - Declaration octobre 2017
French 114.4 KB

Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Valneva SE

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Valneva SE via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-03-18 N/A Other Buy 44,222 N/A
2024-01-03 N/A Other Other 34,802 N/A
2023-06-20 N/A Other Sell 192,547 1,406,228.50 EUR
2023-06-19 N/A Other Sell 30,661 209,629.26 EUR
2023-06-16 N/A Other Sell 85,589 582,493.06 EUR
2023-06-15 N/A Other Sell 28,179 189,503.78 EUR
2023-06-14 N/A Other Sell 228,951 1,519,914.11 EUR
2023-06-13 N/A Other Sell 29,401 187,922.37 EUR
2023-06-12 N/A Other Sell 117,854 733,782.57 EUR
2023-05-10 N/A Other Buy 87,523 N/A

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.